Thema: BE0003739530
UCB, BE0003739530
UCB S.A. (BE0003739530) dokumentarisch: authentische SchwarzweiĂ-Reportage einer Wissenschaftlerin bei sorgfĂ€ltiger Laboranalyse mit Petrischale - Foto: THN
UCB stock: Guidance rests on BIMZELX and CIMZIA demand
UCB stock remains supported by stronger BIMZELX demand and continued CIMZIA volume growth. Investors now await the next earnings update.
ad-hoc-news.de, heute 17:52 Uhr
UCB, BE0003739530
UCB stock: Guidance raised again on strong drug demand
UCB stock follows another upgrade to the company's 2026 outlook. Stronger BIMZELX demand and continued CIMZIA growth support the revised targets.
ad-hoc-news.de, 02.11.26 10:54 Uhr
UCB, BE0003739530
UCB stock gets new US manufacturing boost from $2 billion ...
UCB stock heads into the weekend after a major expansion of its US manufacturing footprint. The project adds long-term capacity for biologic medicines.
ad-hoc-news.de, 31.10.26 10:22 Uhr
UCB, BE0003739530
UCB stock outlook rises as 2026 growth target reaches low ...
UCB stock faces a sharper earnings test after management raised its 2026 outlook. BIMZELX and CIMZIA are the main commercial drivers.
ad-hoc-news.de, 30.10.26 11:27 Uhr
UCB, BE0003739530
UCB stock reaches EUR 278.95 after guidance upgrade
UCB lifted its 2026 revenue and adjusted EBITDA outlook on October 22. Stronger U.S. BIMZELX demand and CIMZIA volume growth supported the change.
ad-hoc-news.de, 29.10.26 17:50 Uhr
UCB, BE0003739530
TD Cowen raises target for UCB stock to EUR 340
Bimzelx sales were EUR 1.52 billion in HY 2026. UCB stock costs EUR 269.50 on October 27, 2026, down 0.30 percent versus Euronext Brussels close.
ad-hoc-news.de, 27.10.26 17:01 Uhr
UCB, BE0003739530
UCB raised 2026 outlook as UCB stock trades at EUR 268.00 ...
UCB expects revenue growth in the low twenties for 2026 at constant exchange rates. UCB stock costs EUR 268.00 in trading on October 27, 2026.
ad-hoc-news.de, 27.10.26 11:23 Uhr
UCB, BE0003739530
TD Cowen lifts target for UCB stock to EUR 340.00
Revenue reached EUR 4.27 billion in the June 30, 2026 period. UCB stock costs EUR 269.55 on October 26, 2026, down 1.16 percent versus the Xetra close.
ad-hoc-news.de, 26.10.26 16:41 Uhr
UCB, BE0003739530
UCB raises 2026 guidance: UCB stock gains 4.54 percent
UCB lifts its 2026 revenue outlook to the low twenties on October 22, 2026. UCB stock costs EUR 275.35, 4.54 percent above its Xetra close.
ad-hoc-news.de, 26.10.26 10:28 Uhr
